Heart disease in cats is most often a primary muscle disorder called hypertrophic cardiomyopathy, not the coronary-artery disease that dominates human cardiology. The disease thickens the left ventricular wall, stiffens the chamber, and impairs filling rather than pumping. Cats frequently hide the resulting congestion until it becomes an emergency. This explainer covers the underlying muscle biology, the breeds and mutations involved, the diagnostic thresholds veterinarians use, and the practical steps that change outcomes.
The failing muscle, one level deeper
The heart's muscular wall is built from cardiomyocytes, and in the most common feline heart disease those cells enlarge individually rather than multiplying. This is hypertrophy without hyperplasia, and it is the core problem. The enlargement is driven partly by sarcomere protein mutations and partly by neurohormonal signaling, including the renin-angiotensin-aldosterone system and sympathetic activation. When sarcomere proteins are abnormal, the force-generating units work inefficiently. The body compensates by thickening the wall, which increases stiffness. A stiffer wall resists filling, so the left ventricle holds less blood at the same pressure.
That sequence explains the paradox at the center of feline cardiology. The heart looks muscular and often contracts vigorously, yet it cannot relax enough to fill. Stroke volume falls, pressures back up into the left atrium and pulmonary veins, and fluid leaks into the lungs. This is congestive heart failure from diastolic dysfunction, a filling problem rather than an ejection problem. The distinction matters clinically because treatments that help a weak, dilated heart do not map cleanly onto a stiff, thick one.
In a smaller subset of cats, the same disease process weakens the wall instead of thickening it. Dilated cardiomyopathy causes a thin, floppy ventricle that cannot squeeze, and it has been linked historically to dietary taurine deficiency corrected in most commercial foods decades ago, though diet-associated cases still appear. A third pattern, restrictive cardiomyopathy, stiffens the muscle with scarring and minimal thickening. All three end in the same place, impaired filling and congestion, but they start from different cellular failures.
How common it is, and who is at risk
Hypertrophic cardiomyopathy is the single most diagnosed heart disease in cats. Prevalence estimates in apparently healthy cats generally fall in a wide range, and screening studies have reported figures from roughly one in seven to well above that depending on the population and the sensitivity of the test used. The honest summary is that a meaningful fraction of cats that look completely normal have some degree of the disease. Many never progress to heart failure, which is why cardiologists distinguish the presence of disease from the presence of clinical illness.
Age and breed shift the odds substantially. The disease is most often detected in middle-aged to older cats, but it appears in young animals too, and the inherited forms can show up early. Certain breeds carry a clearly elevated risk, including the Maine Coon, Ragdoll, British Shorthair, and Persian. Sex appears to matter less than genetics. In pedigree cats with known familial disease, a specific genetic test exists for the Maine Coon and Ragdoll mutations, which allows breeders to screen. For the great majority of cats, no single genetic test is available.
Here is where numbers need care. Sudden death and arterial thromboembolism, a clot that lodges at the aortic bifurcation and cuts off blood to the hind legs, are the feared complications. Thromboembolism is estimated to complicate a minority of affected cats, and the widely cited figure of roughly one to two percent per year applies to cats with advanced disease, not to the entire population. Quoting a single lifetime risk for every cat with a murmur overstates the danger. The realistic picture is that many cats live years with mild disease and die of something else entirely.
The time course, from silent change to crisis
| Stage | What is happening | Typical signs |
|---|---|---|
| Subclinical | Wall thickens; filling pressure begins to rise | None; maybe a murmur or gallop rhythm |
| Early symptomatic | Left atrial enlargement progresses | Reduced activity, subtle breathing change |
| Congestive heart failure | Fluid backs into lungs or chest | Labored breathing, open-mouth breathing, cough uncommon |
| Thromboembolic event | Clot blocks hind-limb circulation | Sudden hind-leg paralysis, pain, cold limbs |
| Refractory disease | Congestion resists treatment | Persistent respiratory distress |
The timeline is unpredictable, which is the hardest part to communicate to owners. A cat can sit in the subclinical stage for years, then decompensate over days. Some cats with severe thickening never develop heart failure, while others with milder disease do. This variability is why the presence of a heart murmur alone does not tell you what will happen next. The trajectory depends on left atrial size, the presence of outflow obstruction, and how the individual muscle responds, not just wall thickness.
The acute crisis usually involves the lungs. When left atrial pressure climbs past the point where lymphatics can clear fluid, pulmonary edema develops. Cats do not cough the way dogs with heart disease do, so owners often miss the warning. Instead the cat breathes faster while resting, may sit with elbows out, and may avoid lying flat. A thromboembolic event tends to be unmistakable and catastrophic, with a cat that was walking suddenly dragging one or both hind legs and crying in pain. That is a same-hour emergency.
What owners and even clinicians get wrong
The most consequential misconception is that a heart murmur equals heart failure. Murmurs are turbulent blood flow, and many are innocent, especially in young cats. A murmur is a reason to listen further and possibly image the heart, not a diagnosis. Conversely, a cat can have significant cardiomyopathy with no murmur at all, because the geometry that produces turbulence may be absent. Relying on the stethoscope alone will miss cases.
Another persistent error is expecting a cough. Cough is a hallmark of heart disease in dogs, driven by airway compression from an enlarged left atrium. In cats, cough is far more often asthma or bronchitis. When an owner reports a coughing cat, the differential should lead toward respiratory disease, with the heart considered but not assumed. This is the counterintuitive detail worth holding onto: the absence of a cough tells you almost nothing about the feline heart, and its presence points somewhere else first.
A third misconception concerns taurine. Many owners assume all modern commercial diets have eliminated taurine deficiency, which is largely but not entirely true. Certain boutique, grain-free, or homemade diets have been associated with dilated cardiomyopathy, and the mechanism is not always simple taurine lack. The professional caveat is that diet-associated heart disease is real, evolving, and not always reversible by supplementation alone, so diet history belongs in every cardiac workup.
Practical steps that change outcomes
Breathing rate is the single most useful home measurement. Count chest movements for thirty seconds while the cat rests and multiply by two, or count for a full minute. A normal resting respiratory rate in a calm cat is generally under about 30 breaths per minute. A sustained rate above 40, especially with effort, warrants urgent veterinary contact. Record the number and the time so the veterinarian has a trend rather than a single snapshot. This one habit catches decompensation earlier than almost anything else an owner can do.
Resting breathing rate persistently above 40 breaths per minute: call the veterinarian the same day. Open-mouth breathing, blue-tinged gums, or gasping: emergency, go now. Sudden hind-leg weakness, dragging, or pain with cold limbs: emergency, clot suspected. Collapse or fainting, even brief: urgent evaluation. A new murmur plus lethargy or reduced appetite: schedule a prompt exam.
Screening is the second lever. The gold standard is echocardiography, which measures wall thickness, chamber size, and function directly. A wall thickness above roughly 6 millimeters in a cat is generally the threshold that raises concern for hypertrophic cardiomyopathy, with values in the 5 to 6 millimeter range considered equivocal and warranting repeat imaging. Breed matters here: normal Maine Coons and Ragdolls can have thicker walls than the general feline threshold, so breed-specific cutoffs are used to avoid overdiagnosis. A blood test called NT-proBNP can support triage but does not replace imaging.
Blood pressure and thyroid status round out the workup, because both cause secondary thickening that can mimic primary disease. Hyperthyroidism and systemic hypertension can each drive the heart to thicken, and treating the underlying cause may allow the heart to normalize. This is why a diagnosis of cardiomyopathy made without checking thyroid and blood pressure is incomplete. When these secondary causes are present, the prognosis and treatment differ.
Limits of what we know
The evidence base has real gaps. There is no large, long-term trial establishing that treating a cat with silent, mild disease prevents progression to heart failure. Treatment decisions in subclinical cats remain individualized and are guided by risk markers such as left atrial enlargement and outflow obstruction, not by a universal protocol. That uncertainty should be stated plainly rather than papered over.
Genetic understanding is also incomplete. A handful of mutations are well characterized, but they explain only part of the disease burden, and most affected cats have no identified single cause. Prognosis tools are imperfect, and the widely used staging frameworks borrowed from human and canine cardiology fit feline disease unevenly. What a veterinarian can do reliably is measure, trend, and respond to change. What no one can do is predict with confidence which mildly affected cat will decompensate next year.
The most defensible guidance is therefore practical and modest. Know the breeds at risk. Measure the breathing rate at home. Treat a murmur as a prompt for imaging, not a verdict. Treat a cough as a respiratory clue first. Check thyroid and blood pressure before accepting a primary muscle diagnosis. And treat sudden hind-leg paralysis or labored breathing as an emergency without waiting to see if it improves. Those steps rest on well-understood physiology and do not depend on numbers we cannot yet supply.
For authoritative background, the American College of Veterinary Internal Medicine and the veterinary cardiology specialty organizations publish consensus guidance on feline cardiomyopathy, and the U.S. Food and Drug Administration maintains information on diet-associated heart disease in animals.